Literature DB >> 28217826

In vivo comparison of two navigation systems for abdominal percutaneous needle intervention.

Deqiang Xiao1,2, Yong Li3, Huoling Luo1,2, Yanfang Zhang4, Xuejun Guo5, Huimin Zheng1, Qingmao Hu1,2, Fucang Jia6,7.   

Abstract

PURPOSE: To compare the accuracy of a Kinect-Optical navigation system with an electromagnetic (EM) navigation system for percutaneous liver needle intervention.
MATERIALS AND METHODS: Five beagles with nine artificial tumors were used for validation. The Veran IG4 EM navigation system and a custom-made Kinect-Optical navigation system were used. Needle insertions into each tumor were conducted with these two guidance methods. The target positioning error (TPE) and the time cost of the puncture procedures were evaluated.
RESULTS: A total of 18 needle insertions were performed to evaluate the navigation accuracy of the two guidance approaches. The targeting error was 6.78 ± 3.22 mm and 8.72 ± 3.5 mm for the Kinect-Optical navigation system and the EM navigation system, respectively. There is no statistically significant difference in the TPE between the Kinect-Optical navigation system and the EM navigation system (p = 0.229). The processing time with the Kinect-Optical system (10 min) is similar to that of the Veran IG4 system (12 min).
CONCLUSIONS: The accuracy of the Kinect-Optical navigation system is comparable to that of the EM navigation system.

Entities:  

Keywords:  Electromagnetic navigation; Kinect camera; Liver; Needle intervention; Optical navigation

Mesh:

Year:  2017        PMID: 28217826     DOI: 10.1007/s00261-017-1083-x

Source DB:  PubMed          Journal:  Abdom Radiol (NY)


  1 in total

1.  Development and clinical evaluation of a contactless operating interface for three-dimensional image-guided navigation for endovascular neurosurgery.

Authors:  Masahiro Nishihori; Takashi Izumi; Yoshitaka Nagano; Masaki Sato; Tetsuya Tsukada; Asuka Elisabeth Kropp; Toshihiko Wakabayashi
Journal:  Int J Comput Assist Radiol Surg       Date:  2021-03-11       Impact factor: 2.924

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.